Researchers at Université de Montréal developed a rapid DNA sensor to detect drug concentrations in blood, promising advancements in monitoring medication and chemotherapy treatments.
- The team at Université de Montréal created signaling cascades using DNA molecules to quantify drug concentrations in blood samples in just 5 minutes.
- This innovative technology, validated through experiments on mouse models, aims to improve pharmacokinetics and reduce side effects associated with various medication therapies.
- Published in the Journal of the American Chemical Society, this method leverages signal transduction principles and could enhance point-of-care devices for monitoring chemotherapy effectiveness.
Why It Matters
This breakthrough in electrochemistry and DNA technology is crucial for developing fast, efficient medical diagnostics, potentially transforming patient care by enabling real-time monitoring of drug efficacy and safety.